Gynuity Health Projects

Quick facts

Marketed products

• Buccal misoprostol
• Mifepristone and misoprostol · Reproductive Health / Obstetrics
  Mifepristone blocks progesterone receptors to stop pregnancy development, while misoprostol causes uterine contractions to expel pregnancy tissue.
• Mifepristone + Misoprostol · Reproductive Health / Gynecology
  Mifepristone blocks progesterone receptors to stop pregnancy maintenance, while misoprostol induces uterine contractions to expel the pregnancy.
• Placebo mifepristone
  This is a placebo formulation with no active pharmacological mechanism.

Phase 1 pipeline

• mifepristone-misoprostol treatment

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Gynuity Health Projects portfolio CI brief
• Gynuity Health Projects pipeline updates RSS